AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Alligator Bioscience

Major Shareholding Notification Nov 15, 2023

3138_iss_2023-11-15_4e74278b-496a-4dbb-8406-4b01f4559e85.pdf

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

Issuer Alligator Bioscience AB

Holder

Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension

Instrument

Instrument Aktier
Before the transaction
Shares Data not given
Data not given
Voting rights
Transaction
Reason for major shareholding notification Share loan
Date 14/11/2023
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 33,957,094
Directly held voting rights 0
Indirectly held voting rights 33,957,094
Percentage
Directly held shares 5.15357 %
Directly held voting rights 0 %
Indirectly held voting rights 5.16027 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 5.16027 % 33,957,094
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 5.16027 % 33,957,094

Group total holdings

Voting rights 33,957,094 Percentage of voting rights 5.16027

Notes (other relevant informations according to law)

Aktierna, samt övriga instrument enligt LHF 4 kap, 2§ första stycket 1 och finansiella instrument enligt LHF 4 kap. 2§ första stycket 3 innehas av Försäkringsaktiebolaget Avanza Pension som är ett helägt dotterbolag till Avanza Bank Holding AB (publ). Angivet gränsvärde har överskridits på grund av retur av utlånade aktier.

Published

15/11/2023 10:22

Contact

Name Marie Andersson

Email [email protected]

*Source of information has chosen not to submit the data

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25

Talk to a Data Expert

Have a question? We'll get back to you promptly.